Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  2-fluoropropionyl-labeled pegylated dimeric RGD peptide
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
18F FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients with Cancer Receiving Anti-Angiogenesis Therapy
Status: Active
Phase: Phase II, Phase I
Type: Diagnostic
Age: 18 and over
Trial IDs: VARIMG0002, NCI-2013-00535, NCT01806675
Start Over